Triera Biosciences announces positive initial test results for a universal aptamer targeting HPAI H5N1, a priority target for governments.
Zentek Ltd.'s subsidiary, Triera Biosciences Ltd., has announced positive initial test results for a universal aptamer targeting highly pathogenic avian influenza (HPAI). The World Health Organization (WHO) considers the current H5N1 outbreak a priority target for numerous governments. Triera aims to develop an avian flu infectious management system combining diagnostics, prophylaxis, and therapeutics using the same multivalent aptamer agent, following promising results in animal models.
May 06, 2024
6 Articles